
Our Specialty Pharmacy Enablement (SPE) expert discusses 3 critical areas of access for the health system specialty pharmacy.
As the cell and gene pipeline swells, collaborative partnerships and digital transformation are critical.
Date
August 23, 2024
By: Joe DePinto
Recently, Joe DePinto, Head of Cell, Gene, & Advanced Therapies at McKesson, was featured on Ori Biotech’s Ori Spotlight Podcast to discuss challenges and innovations in the cell and gene therapy (CGT) manufacturing and supply chains, as well as the impactful role that collaboration and digital transformation can play in improving processes and expanding access to these life-saving therapies. Watch the full video, Joe DePinto: Bridging Growth and Accessibility Within CGT, to learn more.
Our Specialty Pharmacy Enablement (SPE) expert discusses 3 critical areas of access for the health system specialty pharmacy.
One of our McKesson experts discusses the importance of staying informed as 340B changes continue to unfold.
As payer dynamics shift, therapy pipelines grow, and leakage accelerates, health systems leaders should rethink what infusion care can and should be.
A recent podcast includes first-hand insights on opportunities for collaboration in strengthening the supply chain to achieve more.
McKesson’s Head of Cell, Gene, and Advanced Therapies discusses opportunities and challenges with CGT in the health system.
This interactive experience highlights key aspects of our SPE solutions, designed to help your health system achieve more.
The first in a series of interviews with our Specialty Pharmacy Enablement expert, Ginger Thorpe, covering important questions health systems should be asking.
This visual helps illustrate the nuances of each type of bagging in specialty pharmacy and what it may mean for your health system.
As strategic partners, our Specialty Pharmacy Enablement experts can help drive improvements across the board.